{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:03:01Z","timestamp":1789506181504,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370149"],"award-info":[{"award-number":["82370149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170138"],"award-info":[{"award-number":["82170138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2026JJ30091"],"award-info":[{"award-number":["2026JJ30091"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cytogfr.2026.101527","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:28:03Z","timestamp":1788733683000},"page":"101527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytokine release syndrome: Inflammatory signaling, panoptosis, and therapeutic perspectives"],"prefix":"10.1016","volume":"92","author":[{"given":"Wenxi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5375-1654","authenticated-orcid":false,"given":"Jieying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-9805","authenticated-orcid":false,"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib1","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1038\/s41467-022-32960-3","article-title":"CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies","volume":"13","author":"Hu","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib2","article-title":"Cytokine release syndrome following blinatumomab therapy","volume":"14","author":"Ojemolon","year":"2022","journal-title":"Cureus"},{"issue":"17","key":"10.1016\/j.cytogfr.2026.101527_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70069","article-title":"Cytokine release syndrome in solid tumors","volume":"131","author":"Synnott","year":"2025","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.101527_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.101527_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2026.120115","article-title":"The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapy","volume":"1873","author":"Gabriel","year":"2026","journal-title":"Biochim. Et. Biophys. Acta-Mol. Cell. Res."},{"issue":"21","key":"10.1016\/j.cytogfr.2026.101527_bib6","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1158\/1078-0432.CCR-22-3667","article-title":"Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies","volume":"29","author":"Leclercq-Cohen","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.101527_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2026.101527_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111761","article-title":"Multi-centers experience using therapeutic plasma exchange for corticosteroid\/tocilizumab-refractory cytokine release syndrome following CAR-T therapy","volume":"130","author":"Pu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.anai.2022.10.025","article-title":"Interleukin-6 and cytokine release syndrome A new understanding in drug hypersensitivity reactions","volume":"130","author":"Lee","year":"2023","journal-title":"Ann. Allergy Asthma & Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.101527_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.idc.2022.07.001","article-title":"Cytokine Release Syndrome and Sepsis Analogous Clinical Syndromes with Distinct Causes and Challenges in Management","volume":"36","author":"Athale","year":"2022","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"10.1016\/j.cytogfr.2026.101527_bib11","article-title":"Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122158","article-title":"PANoptosis: Emerging mechanisms and disease implications","volume":"333","author":"Qi","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib13","article-title":"CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies","volume":"13","author":"Hu","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.101527_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae124","article-title":"PANoptosis, an indicator of COVID-19 severity and outcomes","volume":"25","author":"Yang","year":"2024","journal-title":"Brief. Bioinforma."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03428-x","article-title":"DAMPs released by pyroptotic cells as major contributors and therapeutic targets for CAR-T-related toxicities","volume":"12","author":"Deng","year":"2021","journal-title":"Cell. Death & Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12013-025-01912-1","article-title":"PANoptosis: Molecular Mechanisms, Regulatory Pathways, and Implications in Disease Pathogenesis","volume":"84","author":"Chowdhury","year":"2026","journal-title":"Cell. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13437","article-title":"Z-Nucleic Acid Sensing and Activation of ZBP1 in Cellular Physiology and Disease Pathogenesis","volume":"329","author":"Mishra","year":"2025","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s40104-024-01107-3","article-title":"The assembly and activation of the PANoptosome promote porcine granulosa cell programmed cell death during follicular atresia","volume":"15","author":"Wu","year":"2024","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib19","article-title":"PANoptosis in Cytokine Release Syndrome: Bridging the Gap between Inflammation and Cell Death","author":"Eltaib","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cytogfr.2026.101527_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-031-59815-9_4","article-title":"Clinical Features of Cytokine Storm Syndrome","volume":"1448","author":"Shimizu","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.101527_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib22","article-title":"Toxicities associated with CAR-T therapy compared with standard treatments in hematologic malignancies: a systematic review and meta-analysis","volume":"26","author":"Ram\u00edrez","year":"2026","journal-title":"Bmc Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.101527_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4103\/1319-2442.390259","article-title":"Cytokine Release Syndrome after Chimeric Antigen Receptor Transduced T-Cell Therapy in Cancers: A Systematic Review","volume":"33","author":"Taheri","year":"2022","journal-title":"Saudi J. Kidney Dis. Transplant."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.101527_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jtct.2025.08.015","article-title":"Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed\/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium","volume":"31","author":"Sweiss","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1158\/2643-3230.BCD-23-0056","article-title":"Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma","volume":"5","author":"Faramand","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.cytogfr.2026.101527_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190379","article-title":"Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures","volume":"14","author":"Shah","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib27","article-title":"The \"cytokine storm\" in infection and sepsis: win the battle but lose the war","volume":"12","author":"Fan","year":"2026","journal-title":"Mil. Med. Res."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/HM9.0000000000000158","article-title":"Electroacupuncture combined with cisplatin induces an effective anti-tumor immune response by protecting chemotherapy-impaired bone marrow hematopoiesis in non-small cell lung cancer mice","volume":"5","author":"Wang","year":"2025","journal-title":"Acupunct. Herbal. Med."},{"issue":"11-12","key":"10.1016\/j.cytogfr.2026.101527_bib30","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s10495-025-02187-w","article-title":"AIM2 regulated by JAK3\/STAT1 pathway promotes PANoptosis in intestinal barrier dysfunction caused by concomitant radiation and PD-1 Blockade","volume":"30","author":"Chen","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.cytogfr.2026.101527_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/discim\/kyac005","article-title":"Looking into the IL-1 of the storm: are inflammasomes the link between immunothrombosis and hyperinflammation in cytokine storm syndromes?","volume":"1","author":"Gleeson","year":"2022","journal-title":"Discov. Immunol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib34","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-187449","article-title":"Mechanistic Studies of Cytokine Release Syndrome (CRS) with Roles of Interferon-Gamma (IFN-g) and Tumor Necrosis Factor Alpha (TNF-\u03b1) While Maintaining CAR-T Function in Vitro","volume":"142","author":"Amatya","year":"2023","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.cytogfr.2026.101527_bib35","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/cmi.2013.59","article-title":"TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells","volume":"11","author":"Fang","year":"2014","journal-title":"Cell. & Mol. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.101527_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/bloodadvances.2019000952","article-title":"Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management","volume":"4","author":"Pennisi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.cytogfr.2026.101527_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7137900","article-title":"Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome","volume":"2022","author":"Chen","year":"2022","journal-title":"Mediat. Inflamm."},{"issue":"23","key":"10.1016\/j.cytogfr.2026.101527_bib39","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2026.101527_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/HM9.0000000000000092","article-title":"Electroacupuncture targeting the immune system to alleviate sepsis","volume":"4","author":"Fang","year":"2024","journal-title":"Acupunct. Herbal. Med."},{"key":"10.1016\/j.cytogfr.2026.101527_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106907","article-title":"Molecular mechanism of PANoptosis and programmed cell death in neurological diseases","volume":"209","author":"Hou","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.101527_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The 'cytokine storm': molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.101527_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.it.2020.10.005","article-title":"Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines","volume":"41","author":"Lee","year":"2020","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib46","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/v16081261","article-title":"Chromatin Regulator SMARCA4 Is Essential for MHV-Induced Inflammatory Cell Death, PANoptosis","volume":"16","author":"Malireddi","year":"2024","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.101527_bib50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2020.07.025","article-title":"Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies","volume":"146","author":"Freyer","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150140","article-title":"Myricetin reduces platelet PANoptosis in sepsis to delay disseminated intravascular coagulation","volume":"724","author":"Zhou","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.101527_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17474086.2019.1585238","article-title":"Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy","volume":"12","author":"Acharya","year":"2019","journal-title":"Expert. Rev. Hematol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.101527_bib53","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3324\/haematol.2023.284564","article-title":"Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies","volume":"109","author":"Perl","year":"2024","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2643-3230.BCD-21-0181","article-title":"Blockade or Deletion of IFN\u03b3 Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies","volume":"3","author":"Bailey","year":"2022","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.cytogfr.2026.101527_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo6294","article-title":"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection","author":"Karki","year":"2022","journal-title":"Science Immunology 8(90"},{"key":"10.1016\/j.cytogfr.2026.101527_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148727","article-title":"Recent advances in ZBP1-derived PANoptosis against viral infections","volume":"14","author":"Oh","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.101527_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06889-y","article-title":"ZBP1 condensate formation synergizes Z-NAs recognition and signal transduction","volume":"15","author":"Xie","year":"2024","journal-title":"Cell. Death & Dis."},{"issue":"18","key":"10.1016\/j.cytogfr.2026.101527_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810224","article-title":"ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity","volume":"23","author":"Hao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-025-10112-9","article-title":"Emerging role of PANoptosis in pathogen infection and systemic diseases","volume":"41","author":"Cai","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1545549","article-title":"Engineering safe anti-CD19-CD28\u03b6 CAR T cells with CD8a hinge domain in serum-free media for adoptive immunotherapy","volume":"16","author":"Muthuvel","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1912393","article-title":"Integrative transcriptomic and experimental analyses prioritize TPT1 as a PANoptosis-associated candidate molecular marker in sarcopenia","volume":"14","author":"Dong","year":"2026","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.101527_bib62","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1039\/D5MO00136F","article-title":"Cytokine-induced memory-like responses in endothelial cells link chronic inflammation to vascular disease risk","volume":"21","author":"Le","year":"2025","journal-title":"Mol. Omics"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib63","article-title":"Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection","volume":"10","author":"Xu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.cytogfr.2026.101527_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2026.117942","article-title":"Targeting microglial TLR3-NF-\u03baB\/MAPK and JAK\/STAT Axis: PEITC as a suppressor of poly (I:C)-induced neuroinflammation","volume":"514","author":"Lan","year":"2026","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.101527_bib65","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050762","article-title":"The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome","volume":"17","author":"Gleeson","year":"2024","journal-title":"Dis. Models & Mech."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molmed.2023.10.001","article-title":"Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes","volume":"30","author":"Pandeya","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.101527_bib68","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.2200508","article-title":"PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality","volume":"209","author":"Pandian","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595722","article-title":"Dynamic Immune\/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer","volume":"12","author":"Rossi","year":"2021","journal-title":"Front. Immunol."},{"issue":"41","key":"10.1016\/j.cytogfr.2026.101527_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503977","article-title":"The NSP5, ORF6 and NSP13 of SARS-CoV-2 Cooperate to Modulate Inflammatory Cell Death Activation","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cytogfr.2026.101527_bib71","article-title":"The regulatory role of IL-37 and IL-38 in CAR-T associated cytokine release syndrome in multiple myeloma","volume":"17","author":"Huang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101524","article-title":"Myeloid dysregulation and therapeutic intervention in COVID-19","volume":"55","author":"Gu","year":"2021","journal-title":"Semin. Immunol."},{"issue":"11-12","key":"10.1016\/j.cytogfr.2026.101527_bib73","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s10495-025-02186-x","article-title":"PANoptosis: potential new targets and therapeutic prospects in digestive diseases","volume":"30","author":"Zhang","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.cytogfr.2026.101527_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0519-7","article-title":"Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia","volume":"10","author":"Fan","year":"2017","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib75","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2020.20417","article-title":"Cardiovascular aspects of COVID-19","volume":"150","author":"Kurz","year":"2020","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.cytogfr.2026.101527_bib76","article-title":"Recent advances of chimeric antigen receptor T-cell therapy for acute myeloid leukemia","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.101527_bib77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00134-021-06416-z","article-title":"Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials","volume":"47","author":"Snow","year":"2021","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-021-00941-2","article-title":"Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials","volume":"11","author":"Belletti","year":"2021","journal-title":"Ann. Intensive Care"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.101527_bib79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/HM9.0000000000000175","article-title":"Traditional Chinese medicine for long COVID-19: the potential roles of immunity remodeling","volume":"5","author":"Qianru","year":"2025","journal-title":"Acupunct. Herbal. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.101527_bib80","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.3390\/curroncol30050378","article-title":"Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications","volume":"30","author":"Mucha","year":"2023","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.101527_bib83","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"New. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.101527_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101287","article-title":"Toxicities associated with adoptive cellular therapies","volume":"34","author":"Hansen","year":"2021","journal-title":"Best. Pract. & Res. Clin. Haematol."},{"issue":"45","key":"10.1016\/j.cytogfr.2026.101527_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp7160","article-title":"Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03301-1","article-title":"Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy","volume":"44","author":"Cai","year":"2025","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.101527_bib87","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.apsb.2024.12.014","article-title":"Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H(2)S-amplified nanoformulation to enhance cancer immunotherapy","volume":"15","author":"Luo","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib88","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02130-8","article-title":"Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib89","first-page":"928","article-title":"Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma","volume":"22","author":"Xiang","year":"2025","journal-title":"Cancer Biol. & Med."},{"key":"10.1016\/j.cytogfr.2026.101527_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1198713","article-title":"The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas","volume":"16","author":"Song","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.101527_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkaf283.106","article-title":"IL-9 signaling enhances CAR T cell antitumor efficacy in solid tumors by promoting memory phenotypes and reducing dysfunction under antigen stress","volume":"214","author":"Castelli","year":"2025","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.101527_bib92","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood-2018-10-881722","article-title":"GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts","volume":"133","author":"Sterner","year":"2019","journal-title":"Blood"},{"issue":"499","key":"10.1016\/j.cytogfr.2026.101527_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5907","article-title":"The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T cells","volume":"11","author":"Mestermann","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"24","key":"10.1016\/j.cytogfr.2026.101527_bib94","doi-asserted-by":"crossref","first-page":"22206","DOI":"10.1002\/cam4.6803","article-title":"PANoptosis in cancer, the triangle of cell death","volume":"12","author":"Cai","year":"2023","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.101527_bib95","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202305026","article-title":"TNF and IFN\u03b3-induced cell death requires IRF1 and ELAVL1 to promote CASP8 expression","volume":"223","author":"Deng","year":"2024","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2026.101527_bib96","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2025-2328","article-title":"New evidence that complement activation and NLRP3 inflammasome signaling work together to cause cytokine release syndrome after CAR-T cell therapy","volume":"146","author":"Wierzbicka","year":"2025","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.101527_bib97","doi-asserted-by":"crossref","DOI":"10.1007\/s13730-025-01086-y","article-title":"Successful use of Remcyte\u00ae-based continuous hemodiafiltration in a case of refractory CRS and ICANS complicated by tumor lysis syndrome-associated AKI","volume":"15","author":"Yomogida","year":"2026","journal-title":"Cen. Case Rep."},{"issue":"11-12","key":"10.1016\/j.cytogfr.2026.101527_bib98","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s10495-025-02173-2","article-title":"Role of PANoptosis in cancer: Molecular mechanisms and therapeutic opportunities","volume":"30","author":"Wang","year":"2025","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib99","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-025-05125-9","article-title":"Pseudorabies virus infection induces lymphocyte depletion associated with cellular apoptosis and endoplasmic reticulum stress in the mouse spleen","volume":"21","author":"Liu","year":"2025","journal-title":"Bmc Vet. Res."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.101527_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2025.100239","article-title":"Pattern recognition receptors and inflammasome: Now and beyond","volume":"48","author":"Oh","year":"2025","journal-title":"Mol. Cells"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.101527_bib101","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10067-025-07354-7","article-title":"Electroacupuncture delays the progression of juvenile collagen-induced arthritis via regulation NLRP3\/ NF-\u03baB signaling pathway -mediated pyroptosis and its influence on autophagy","volume":"44","author":"Khadour","year":"2025","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.101527_bib102","article-title":"Piezo1 promotes M1 macrophage polarization and impairs osteogenic differentiation in bone infection","volume":"1872","author":"Yang","year":"2026","journal-title":"Biochim. Et. Biophys. Acta-Mol. Basis Dis."},{"key":"10.1016\/j.cytogfr.2026.101527_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105379","article-title":"Mechanistic insights and regulatory strategies of ZBP1 in tumorigenesis, progression, and cancer therapy","volume":"224","author":"Wei","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.101527_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14096","article-title":"COVID-19 illness: different comorbidities may require different immunological therapeutic targets","volume":"53","author":"Gremese","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.101527_bib105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.3455","article-title":"Cytokine storms in COVID-19, hemophagocytic lymphohistiocytosis, and CAR-T therapy","volume":"8","author":"Long","year":"2025","journal-title":"Jama Netw. Open."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:05:52Z","timestamp":1789502752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":105,"alternative-id":["S1359610126000729"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.101527","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine release syndrome: Inflammatory signaling, panoptosis, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.101527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101527"}}